Название продукции:5-Fluoro-2-(trifluoromethyl)aniline

IUPAC Name:5-fluoro-2-(trifluoromethyl)aniline

CAS:827-20-3
Молекулярная формула:C7H5F4N
Чистота:95%+
Номер в каталоге:CM255193
Молекулярная масса:179.12

Упаковочная единица Доступно для заказа Цена ($) Количество
CM255193-5g in stock ȌdžƋ
CM255193-10g in stock ɐȌƤ
CM255193-25g in stock džȱƋ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:827-20-3
Молекулярная формула:C7H5F4N
Точка плавления:-
Smiles-код:NC1=C(C=CC(F)=C1)C(F)(F)F
Плотность:
Номер в каталоге:CM255193
Молекулярная масса:179.12
Точка кипения:185.6°C at 760 mmHg
Номер Mdl:MFCD06660353
Хранение:Keep in dark place, inert atmosphere, store at 2-8°C.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

PF-06648671
The Journal of Medicinal Chemistry recently publishes an article titled, “Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease”. Amyloid β-peptide (Aβ) accumulation is one of the key hallmarks of Alzheimer’s disease (AD). γ-secretase cleaves the amyloid precursor protein (APP) into pathologically relevant Aβs, and has been widely studied as a potential target for the treatment of AD.
Pfizer‘s PF-06648671 is a Gamma secretase modulator (GSM) targeting APP processing. It is found to have excellent central exposure in human and robust reduction of amyloidogenic forms (Aβ42) in cerebrospinal fluid (CSF).